NTI awards $295,172 to BMC chief for acute lung injury study

NewsGuard 100/100 Score

Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center (BMC) and an associate professor of medicine at Boston University School of Medicine (BUSM), has received a $295,172 grant from the National Trauma Institute (NTI) to identify optimal treatment methods for acute lung injury (ALI). BMC will lead the multi-institutional trial, which involves seven level one trauma centers and includes one military hospital.

Agarwal's study is one of nine grants awarded this year by NTI, a non-profit organization dedicated to funding trauma research in the United States in an effort to reduce death and disability, and the associated costs, related to trauma injury.

Agarwal will study two therapies that may influence ALI, a significant healthcare burden for both military and civilian populations that accounts for more than 75,000 deaths annually. Mechanical ventilation (respirator) techniques remain the only accepted treatment therapy for patients with severe injuries, but these are also associated with segmental lung collapse, increased time on a ventilator and increased incidence of pneumonia. Agarwal's team will compare a novel therapy, airway pressure release ventilation (APRV), with ARDSNet (Acute Respiratory Distress Syndrome), the traditional modality for management of ALI.

"Our long-term goal is to improve the health outcomes of patients with ALI and ARDS and gain a better understanding of its pathogenesis, prevention and treatment," said Agarwal.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis